The European Society of Clinical Pharmacy has published a new edition ofits European Drug Index, which provides a quick reference by trade name of drugs available on the market in 22 European countries. The Index is available as a book and Microsoft Windows-compatible CD-ROM.
The fourth edition of the Index now includes data from three new countries; Rumania, Russia and Turkey. The format has not changed significantly from previous editions, and includes an alphabetical listing by trade name, followed by the manufacturer, dosage forms, and strength, volume and generic names of the active principles. The entry is concluded where possible by the World Health Organization's ATC (Anatomical Therapeutic Chemical) classification and a code for the country of origin, and there is a dictionary which gives English translations for the names of commonly-used dosage forms in other languages.
The European Drug Index 4th revised edition is available at a prepublication price of 298 Deutschemarks (around $175) until June 30, and 348 marks thereafter. The CD-ROM format costs 490 marks. For details contact Deutscher Apotheker Verlag. Phone: +49 711 2582-341 or +49 711 2582 343; Fax: +49 711 2582 290.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze